Various contract research organizations provide biomarker research services for the discovery, development, testing, and validation of biomarkers. These organizations provide different types of biomarker research services to their customers, such as commercialization, biomarker validation, research assay optimization, verification, qualification, and biomarker discovery. Biotechnology companies, pharmaceutical organizations, and research institutes partner or collaborate with service providers for commercialization, validation, and development of biomarkers, as well as companion diagnostic.
For instance, in 2019, BioIVT collaborated with the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium to develop and support research to qualify promising biomarkers for improving clinical practice, predicting therapeutic response, or diagnosing diseases. BioIVT provides services in various countries worldwide, such as the U.S., the U.K., Singapore, Italy, etc. Biomarker research services are specifically provided for the development and validation of new biomarkers.